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Pluripotency in embryonic stem cells is maintained through the activity of a small set of
transcription factors centred around Oct4 and Nanog, which control the expression of ‘self-renewal’
and ‘differentiation’ genes. Here, we combine single-cell quantitative immunofluorescence
microscopy and gene expression analysis, together with theoretical modelling, to investigate how
the activity of those factors is regulated. We uncover a key role for post-translational regulation in
the maintenance of pluripotency, which complements the well-established transcriptional
regulatory layer. Specifically, we find that the activity of a network of protein complexes involving
Nanog, Oct4, Tcf3, and b-catenin suffices to account for the behavior of ES cells under different
conditions. Our results suggest that the function of the network is to buffer the transcriptional
activity of Oct4, which appears to be the main determinant to exit pluripotency. The protein network
explains the mechanisms underlying the gain and loss of function in different mutants, and brings
us closer to a full understanding of the molecular basis of pluripotency.
Molecular Systems Biology 9: 694; published online 8 October 2013; doi:10.1038/msb.2013.49
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Introduction
Embryonic stem (ES) cells are clonal cell populations derived
from mouse pre-implantation embryos that, upon differentia-
tion, give rise to derivatives of all the lineages of an organism
and, under certain culture conditions, propagate this capacity,
that is, they are pluripotent (Bradley et al, 1984; Smith, 2001).
Genetic andmolecular analyses have revealed a small network
of transcription factors centred around the activity of Pou5f1/
Oct4 (Oct4) and Nanog that is necessary and sufficient to
establish and maintain pluripotency in ES cells, as well as to
drive the reprogramming of differentiated cells into this state
(Silva and Smith, 2008; Young, 2011).
Analysis of the expression of Oct4 and Nanog in standard self-
renewal conditions, for example, Serum and LIF (Sþ L), reveals
a high degree of heterogeneity in gene expression and protein
levels (reviewed in Martinez Arias and Brickman, 2011). This is
particularly obvious for Nanog, which exhibits a wide range of
expression levels that are functionally significant: populations of
cells with high levels of Nanog have a higher probability to self-
renewwhilewith low levels are prone to differentiate (Chambers
et al, 2007; Kalmar et al, 2009;Miyanari and Torres-Padilla, 2012;
Navarro et al, 2012). In contrast, the expression of Oct4 is tightly
regulated, with deviations of Oct4 levels from a set range of
values resulting in differentiation (Niwa et al, 2000, 2002).When
ES cells are grown in the presence of PD03, an inhibitor of the
ERK kinase MEK, and Chiron, an inhibitor of GSK3 (2i
conditions), they exhibit high levels of Nanog and Oct4 and do
not differentiate; this state has been termed as the ‘ground state’
of pluripotency (Ying et al, 2008;Wray et al, 2010). The effects of
2i are thought to be mediated by the convergent activity of the
inhibitors: PD03 increases the frequency of Nanog expression
(Lanner et al, 2010; Miyanari and Torres-Padilla, 2012) while
Chiron acts on b-catenin to neutralize the repressing activity of
Tcf3 on the pluripotency network (Wray et al, 2011; Martello
et al, 2012; Shy et al, 2013). Consistent with this interpretation,
Fgf-driven ERK signalling, loss of b-catenin, or increases in Tcf3,
result in loss of pluripotency and differentiation (Pereira et al,
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2006; Kunath et al, 2007; Lyashenko et al, 2011; Wray et al, 2011;
Yi et al, 2011). Despite these observations, the molecular
mechanisms that establish and maintain pluripotency remain
open to discussion.
Recent results have revealed the existence of protein
complexes involving b-catenin, Nanog, Oct4, and Tcf3, which
are associated with pluripotency in ES cells (Wang et al, 2006;
Takao et al, 2007; Abu-Remaileh et al, 2010; Kelly et al, 2011; Ding
et al, 2012; Costa et al, 2013; Faunes et al, 2013; Zhang et al,
2013). Here,we use a combinationof experiments andmodelling
to show that the relative amounts of these complexes are
established by a dynamic competition between their individual
elements, and suggest that their function is to buffer the
differentiation-promoting activity of Oct4. Thus, the stability of
the pluripotent state of ES cells is likely to be determined by the
dynamic balance of the protein complexes, and can be expected
to be associated with the ratios between their components.
Results
Oct4/Nanog complex formation as the molecular
basis of pluripotency: the NOC model
Quantitative immunofluorescence (QIF) of single mES cells
shows that pluripotency is associated with specific ratios,
rather than absolute levels, of Oct4 and Nanog protein
expression (Mun˜oz Descalzo et al, 2012). These ratios manifest
themselves as correlations between the levels of Oct4 and
Nanog that increase when ES cells are cultured in 2i conditions
(Figure 1A and B). A salient feature of the joint distribution of
Oct4 andNanog levels in single cells is a sharp boundary below
which no cells can be found in self-renewing conditions
(Mun˜oz Descalzo et al, 2012, see also Figure 1A). This
boundary represents a lower limit to the levels of Oct4 that a
cell can have for a given amount of Nanog, and its tilted layout
indicates that this limit varies with the latter. Current
mathematical models of pluripotency focus on transcriptional
control and cannot reproduce such a constraint. For example,
an excitable transcriptional system driven by fluctuations in
Nanog expression (Kalmar et al, 2009; see also Supplementary
Figure S1) captures the dynamical features of Nanog gene
expression in a pluripotent cell population, but is unable to
reproduce the observed correlations of protein expression (see
Supplementary Figure S1C and Supplementary information for
additional considerations). This raises the possibility that post-
transcriptional and post-translationalmechanisms, which have
been shown to be associated with ES cells (Sampath et al, 2008;
Buckley et al, 2012; Faunes et al, 2013; Sanchez-Ripoll et al,
2013), contribute to the regulation of pluripotency. In support
of this, treatment of mES cells with a proteasome inhibitor for
2 h increases the levels of Oct4 and Nanog, reducing the
heterogeneity in Nanog expression (Figure 1C; Supplementary
Figure S2). These observations have led us to consider the role
that post-translational regulatory mechanisms have in the
regulation of the levels of Nanog and Oct4 in ES cells.
To test the relevance of post-translational regulation in
pluripotency, we first consider a minimal network involving
Oct4 and Nanog (Figure 1F), on the assumption that the
correlations between these two proteins result from the
formation of a complex (O:N) that has been previously
described experimentally (Wang et al, 2006; Zhang et al,
2007; van den Berg et al, 2010; Ding et al, 2012; Fidalgo et al,
2012). In this minimal model (NOC model, for Nanog-Oct4-
Complex), we assume that Oct4 and Nanog exist in one of the
two forms: either free or bound together in a complex. We do
not exclude the possibility that the free forms of Nanog and
Oct4 interact with other proteins to exert additional functions
(see below). This model aims to describe the stochastic
dynamics of Oct4 and Nanog expression and translation
without relying on any specific transcriptional regulation (see
Supplementary information). The model surmises that in mES
cells Nanog is transcribed in infrequent bursts, as observed
experimentally (Figure 1H and I; Supplementary Figure S4A
and C; Miyanari and Torres-Padilla, 2012; Navarro et al, 2012).
The parameters associated with the transcriptional interac-
tions are chosen to fit these expression data. The model also
assumes that free Nanog is degraded at a rate faster than free
Oct4, but that it is stabilized by forming a complex with Oct4.
Stochastic simulations of this system for basal parameters
representing Sþ L conditions reproduce, to a good approxima-
tion, the experimentally observed protein distributions and
correlations for Nanog and Oct4 (Figure 1D and G).
We next ask whether the model is able to reproduce the
correlations between Nanog and Oct4 observed when cells are
cultured in 2i. We implement this using the observation that in
this condition there is an increase in the number of cells with
higher Nanog mRNA levels (Figure 1H and I) and represent
this by continuously feeding the system with newly synthe-
sized Nanog molecules (Supplementary Figure S4B and D).
Assuming a sufficiently high affinity of Oct4 for Nanog, the
high levels of Nanog in 2i (Supplementary Figure S4E)
will drive most of the available Oct4 into the complex and
ensure that only levels close to a given ratio (corresponding
to the lower boundary of the scatter plot in Sþ L) are
occupied (Figure 1E and G). Simulations of the model
reproduce the observation that the ground state is not
associated with a particular level of Oct4 and Nanog,
but rather with a continuum of levels that lie along a straight
line in the Nanog-Oct4 plane (Mun˜oz Descalzo et al, 2012;
Supplementary Figure S4G and H).
While this minimalistic model can account for the correla-
tions between Oct4 and Nanog in the ground state, it cannot
explain some important observations. In particular, it does not
include b-catenin, whose levels have been shown to have a
significant role in the regulation of the pluripotency network
(Lyashenko et al, 2011; Wray et al, 2011; Faunes et al, 2013).
Most significantly, according to the model, the absence of
Nanog should lead to elevated levels of free Oct4, which
experimentally has been shown to promote differentiation,
and yet Nanog mutant cells remain pluripotent (Chambers
et al, 2007). This suggests that additional elements and
interactions need to be incorporated into the model.
A protein interaction network involving Oct4,
Nanog, and b-catenin underlies naı¨ve
pluripotency: the TBON model
Molecular analyses have revealed a dual role for b-catenin in
the maintenance of pluripotency: alleviating the repressive
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activity of Tcf3 on Nanog (Wray et al, 2011; Martello et al, 2012;
Zhang et al, 2013) and through a complex with Oct4 (Takao
et al, 2007; Abu-Remaileh et al, 2010; Kelly et al, 2011; Ding
et al, 2012; Faunes et al, 2013). To add these interactions to the
NOC model, we first analyzed the experimental distributions
of b-catenin in relation to those of Oct4 and Nanog at the level
of single cells (Figures 1A, B, and 2A).
Under standard growth conditions, there is no clear
correlation between the levels of b-catenin and Nanog (b/N),
and the correlation between b-catenin and Oct4 (b/O) is weak
(Figures 1A and 2E, left gray bars). In contrast, when cells are
cultured in 2i, the b/N and b/O correlations increase
significantly, indicating that they represent features of
ground-state pluripotency (Mun˜oz Descalzo et al, 2012)
(Figures 1B and 2E, right gray bars). As in the NOC model,
we consider that these correlations might be caused in part by
the existence of constrained interactions of b-cateninwith Oct4
and Nanog, in the form of protein complexes that have been
detected (Wang et al, 2006; Takao et al, 2007; Zhang et al, 2007;
Abu-Remaileh et al, 2010; van den Berg et al, 2010; Kelly et al,
2011; Ding et al, 2012; Faunes et al, 2013; Zhang et al, 2013),
and use this to expand the NOC model. The resulting model,
TBON (for Tcf3, b-catenin, Oct4 and Nanog) (Figure 2B),
considers the existence of four protein complexes, O:N, b:O,
b:T, and b:O:N, which compete for their individual compo-
nents, and includes assumptions for which there is experi-
mental evidence. These assumptions can be summarized as
follows:
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Figure 1 The NOC model. (A, B) Scatter plots showing Nanog (x axis), Oct4 (y axis), and b-catenin (heat map, bottom bar) levels, in fluorescence arbitrary units (a.u.)
here and in subsequent similar graphs, in single E14Tg2A cells under standard Serumþ LIF (Sþ L) conditions (A) and 2iþ LIF (2iþ L) conditions (B). Each dot
represents the levels in a single cell. (C) Representative confocal images of Nanog protein expression in E14Tg2A cells grown in Sþ L (left panel) and treated with the
proteasome inhibitor MG132 for 2 h (Sþ LþMG, right panel) before fixation. Scale bar: 50 mm. (D, E) Numerical simulation results in standard Sþ L (D) and 2iþ L
(E) conditions. Blue dots represent protein levels of cells sampled from the model simulations. For simplicity, here and in subsequent figures, we include a light vanilla
background when showing modelling results. (F) Scheme of the core protein NOC network, including Nanog (N), Oct4 (O), and the Oct4:Nanog (O:N) complex.
(G) Pearson’s correlation coefficient between Oct4 and Nanog from the experimental data (gray bars), and the simulations (black bars), in cells cultured in Sþ L and
2iþ L. The error bars in the experimental data indicate 95% CI of bootstrapping distribution, here and in similar subsequent graphs. (H) Representative RNA-FISH
images of EB5 cells grown in Sþ L (left) or 2iþ L (right) and hybridized against Nanog mRNA using a Cy5-labeled probe (red channel), nuclei are shown in blue.
(I) Distributions of Nanog mRNA molecules number in cells grown in Sþ L (light-blue line) and 2iþ L (dark-blue line) obtained from the hybridization experiment
shown in (H).
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(i) Tcf3 inhibits Nanog expression via a direct transcriptional
interaction (Pereira et al, 2006; Yi et al, 2008; Martello
et al, 2012; Shy et al, 2013; Zhang et al, 2013).
(ii) The impact of 2i on the network has two separate effects:
(a) an increase in the levels of b-catenin as a consequence
of Chiron and (b) an increase in the levels of Nanog
expression as a consequence of PD03 (Lanner et al, 2010;
Wray et al, 2010; Wray et al, 2011; Luo et al, 2012;
Miyanari and Torres-Padilla, 2012).
(iii) The model considers the existence of three binary
complexes: Oct4 with Nanog (O:N, Wang et al, 2006;
Zhang et al, 2007; van den Berg et al, 2010; Fidalgo et al,
2012); b-catenin with Oct4 (b:O, Takao et al, 2007; Abu-
Remaileh et al, 2010; Kelly et al, 2011; Ding et al, 2012;
Faunes et al, 2013); and b-catenin and Tcf3 (b:T, Yi et al,
2011; Shy et al, 2013). Experimentally, we could detect a
small amount of Nanog in the b:O complex which
prompted us to include a b-catenin:Oct4:Nanog (b:O:N)
ternary complex in the model.
(iv) There is a hierarchy in the half-lives of the elements of the
network, and also in the stabilities of the complexes, that
can be arranged from less to more stable as: NanogoOc-
t4oO:NoT, b:Tob:O:N, b:O, and b. This hierarchy of
degradation rates is compatible with our experimental
observations of the stability of the different protein
species of the network (Figure 2H; Supplementary
Figure S3).
(v) The total amount of b-catenin in the system is unlimited,
but only a fraction of it is available to the pluripotent
protein network. The available amount of b-catenin
t
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Figure 2 The TBON model. (A) Representative confocal images of E14Tg2A cells stained for Tcf3 (green), Nanog (red), Oct4 (magenta), and total b-catenin (white)
grown in Sþ L (upper panels) and 2iþ L (lower panels). Scale bar: 50 mm. (B) Scheme of the core protein TBON network. See text for details. (C, D) Numerical
simulation of the model for Nanog (x axis), Oct4 (y axis), and b-catenin (heat map) levels in standard Sþ L (C) and 2iþ L (D) conditions; compare with the experimental
data shown in Figure 1A and B. Each dot is a cell sampled from the model simulations. (E) Pearson’s correlation coefficient between Oct4 and Nanog (O/N), b-catenin
and Nanog (b/N), and b-catenin and Oct4 (b/O) from the experimental data (gray bars) and from the TBON simulations (black bars), in cells cultured in Sþ L and 2iþ L.
(F,G) Pie charts showing the relative pools of Nanog, Oct4, b-catenin, and Tcf3 found as free molecules (dark colors) or as part of a complex (pale colors), as determined
by the TBON model in cells grown in Sþ L (F) or 2iþ L (G). The area of each circle is proportional to the total amount of each respective molecule and so are the circle
sectors to the corresponding free proteins and complexes. (H) The plot shows the mean and standard deviation of 2–4 independent experiments of Nanog and Oct4 half-
lives in the indicated genotypes and culture conditions.
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varies from cell to cell, as we see experimentally
(Figure 1A; Supplementary Figure S6C) and allows us
to introduce a dynamic intercellular heterogeneity in
b-catenin levels.
In the model, the activity of the individual factors is altered
when they become part of a complex; for instance, Tcf3 is
unable to repress Nanog expression when in complex with
b-catenin (b:T) (Shy et al, 2013; Zhang et al, 2013). Stochastic
simulations of the TBON model (see Supplementary
information for details) reproduce the experimental protein
distributions and correlations among all the elements of the
extended network in different culture conditions (Figure 2C–E
and compare Supplementary Figure S6A–D with E–H). Most
significantly, this model, and its underlying set of interactions,
provides a framework to understand the dynamics of the key
proteins required for the maintenance of pluripotency, which
ultimately relies on the relative levels of Tcf3, b-catenin,
Oct4, and Nanog, found as either part of a complex or as
free molecules in individual cells. The model shows that
competition between the complexes for their common
components leads to a balanced equilibrium that is dependent
on the culture conditions (Figure 2F and G; Supplementary
Figure S6L and M). The key element of the competition is the
association and dissociation dynamics of the different com-
plexes, together with the differential degradation kinetics of
the different species. A comparison between Figure 2F and G
shows that the b:O, b:T, and b:O:N complexes should be found
more readily in 2i conditions than in Sþ L, whereasmore ‘free’
Oct4 and Tcf3 will exist in Sþ L than in 2i, as it is found
experimentally (Faunes et al, 2013). As a result, Nanog and
Oct4 should be more stable in 2i, where their expression
correlates, which is what we find experimentally (Figure 2H).
The model allows a detailed dissection of the effects of each of
the inhibitors of 2i, thus helping us to understand how the
effects of Chiron and PD03 combine to maintain pluripotency
(Supplementary Figure S8).
We surmise that the main function of the complexes is to
stabilize ground-state pluripotency through the attenuation of
the activity of Oct4, represented by free Oct4, which has been
shown to lead to differentiation when in excess (Niwa et al,
2000; Nishiyama et al, 2009, 2013; Karwacki-Neisius et al,
2013; Radzisheuskaya et al, 2013). A bioinformatic analysis of
the targets of Oct4 and Nanog supports this contention, and
shows that although Oct4 and Nanog bind to many common
sites in the genome, their effects on gene regulation are not the
same (Figure 3; Supplementary Figure S9). Jointly regulated
genes, which might be associated with high and correlated
(balanced) levels of Nanog and Oct4, are mostly associated
with pluripotency (Figure 3A). On the other hand, the unique
targets of Nanog, and most clearly Oct4, include a number
of transcription factors and signalling molecules associated
with the emergence of germ layers and body patterning (Hox,
Sox, Smad, Fgf, Wnt, Nodal signalling; see Figure 3B and
Supplementary Figure S9, and also Niwa et al, 2005;
Nishiyama et al, 2009, 2013; Loh and Lim, 2011; Iwafuchi-
Doi et al, 2012). This analysis supports the notion that a main
function of the protein complexes is to buffer the amount of
Oct4 available to trigger differentiation, thus maintaining the
activity of the pluripotency network.
State of pluripotency in the absence of the protein
network components
The results and model presented here create a framework to
analyze mutants, gain some insights into the molecular basis
for their phenotypes, and thereby on the mechanisms under-
lying the maintenance of pluripotency in wild-type conditions.
For example, Nanog is a key element of the ES cell regulatory
network but, surprisingly, while it is absolutely required for
the establishment of pluripotency (Silva et al, 2008, 2009;
Theunissen et al, 2011), its removal in an established ES cell
population only affects the frequency of differentiation of the
mutant cells but does not abolish pluripotency (Figure 4A;
Supplementary Figure S10; Chambers et al, 2007). The model
predicts that in the absence of Nanog there will be an increase
in the levels of b-catenin that will bind Oct4 and that the
increase in the b:O complex is what maintains, albeit unstably,
pluripotency in these cells (compare Figure 2F and 4B, and see
also Supplementary Figure S11). Nanog mutant cells, as
predicted by the model (Supplementary Figure S11), exhibit
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an increase in the levels of total Oct4 and b-catenin (Figure 4C)
as well as in their correlation (Figure 4D), which indicates that
the frequency of differentiation is very sensitive to the levels of
b-catenin. Consistent with this prediction, we observe that the
pluripotency of the Nanog mutant cells is completely
dependent on Chiron (Figure 4A; Supplementary Figure
S10). As Nanog is the least stable component of the network,
our framework suggests that in its absence, the stability of the
other components should not be significantly altered. This is
precisely what we observe: Oct4 half-life does not change in
the absence of Nanog (Figure 2H).
Our model is also able to reproduce and provide a molecular
understanding of the phenotype of b-catenin mutant ES cells,
which can be unstablymaintained in 2iþ LIF (Wray et al, 2011;
Faunes et al, 2013). Although the levels of total Oct4 and
Nanog are low in the absence of b-catenin (Supplementary
Figure S12A and B; Faunes et al, 2013), the O/N correlation in
these cells is not very different from that of the parental cell
line (Supplementary Figure S12K) (Mun˜oz Descalzo et al,
2012), which is in agreement with the notion that a high O/N
correlation is a central feature of pluripotency. The model
reproduces this situation (Figure 5A; Supplementary Figure
S12E–H and K) and suggests an explanation for it: the absence
of b-catenin will increase the levels of Tcf3 (Figure 5B) that, in
turn, will inhibit Nanog expression, lowering the amount of
the O:N complex, thus contributing to the instability of the
mutant cells. Our framework predicts that if we decrease the
levels of b-catenin, the half-life of Oct4 decreases by 40%
which is compatible with experimental observations. On the
other hand, the half life of Nanog is predicted to decrease by
16%, which might not be experimentally detectable (b-
cateninþ / cells; Figure 2H). Interestingly, we do not observe
a further decrease in the complete absence of b-catenin,
suggesting that the stability of only a fraction of Oct4 is
regulated by b-catenin. All together, these results provide an
explanation for why b-catenin, although not absolutely
necessary for self-renewal (Lyashenko et al, 2011; Wray et al,
2011; Rudloff and Kemler, 2012), is essential for the robustness
of pluripotency. Consequently, b-cateninmutant cells exhibit a
higher rate of differentiation, as has been observed (Wray et al,
2011; Faunes et al, 2013).
The ability of the model to reproduce and explain mutants
with weakened pluripotency is important, but there are also
mutants, in particular Tcf3 mutants, that have been suggested
to exhibit increased pluripotency (Pereira et al, 2006; Yi et al,
2008; Guo et al, 2011). It is thought that the pluripotency of Tcf3
mutants is due to increased levels of Nanog, but we also
observe a decrease in the levels of Oct4 and b-catenin, and a
collapse of the O/N correlation, as cells with low O/N ratio
cross the lower boundary (Figure 5C; Supplementary Figure
S14A–F; Mun˜oz Descalzo et al, 2012). Introducing these
experimental observations in the TBON model (see
Supplementary information), we can reproduce the measured
decrease in O/N correlation, suggesting that the excess Nanog
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quenches any excess Oct4 (Figure 5D; Supplementary Figure
S14G–M). The absence of free Oct4 molecules in the Tcf3
mutant cells would explain the delayed differentiation of Tcf3
mutant cells (Pereira et al, 2006; Yi et al, 2008).
Finally, we examined the response of the TBON circuit to
perturbations in Oct4. Loss of Oct4 results in the loss of
pluripotency (Niwa et al, 2000, 2002) and our model suggests
that this is due to a breakdown in the balance of protein
complexes. The result of the new steady state is a larger pool of
free Nanog, which is subject to fast degradation (Figure 6A;
Figure 2H; see also Supplementary Figure S15). This can also
be seen in Figure 6B and C, which compares the experimental
and numerical observations. This decrease in the levels
of Nanog emulates the situation of the Nanog null cells,
which are more prone to differentiation (Figure 4A and
Supplementary Figure S10, see also Chambers et al, 2007).
Conversely, overexpression of Oct4 will alter the O/N ratio,
freeing up Oct4 (Figure 6D and F; Supplementary Figure S16F)
and leading to the expression of its unique targets and
therefore to differentiation, as observed experimentally
(Niwa et al, 2000; Nishiyama et al, 2009). The excess of Oct4
can be buffered by either excess Nanog (Theunissen et al,
2011) or b-catenin (Faunes et al, 2013; Supplementary Figure
S16F), leading to O:N, b:O, and b:O:N complexes (Figure 6D)
that will suppress Oct4-driven differentiation.
Discussion
We have shown that a competitive network of protein
complexes involving Oct4, Nanog, Tcf3, and b-catenin can
account for the major characteristics of pluripotency in mouse
ES cells. At the centre of this network is the transcriptional
activity of Oct4, whose levels are crucial for the maintenance
of pluripotency and differentiation (Niwa et al, 2000, 2002;
Nishiyama et al, 2009). We suggest that the Oct4 levels are
dynamically buffered through the interactions of three protein
complexes (O:N, b:O, and b:O:N) that compete for their
common elements. The result of this competition is that the
levels of Oct4 are restricted to a range that promotes
pluripotency though fluctuations in those levels lead to cells
with higher differentiation-promoting potential. The variety of
experimental conditions and cell lines analyzed here, together
with the expression profiles and protein stability data
obtained, provide us with strong constraints for establishing
the region of parameter space in which our model operates.
Yet, a systematic sensitivity analysis (Supplementary
Figure S7) shows that the model is robust to the parameters
chosen. A prediction of our model that the lower the levels of
Oct4, the higher the degree of pluripotency, finds support on
recent experiments that show that cells with low stable levels
of Oct4 are unable to exit pluripotency (Karwacki-Neisius et al,
2013; Radzisheuskaya et al, 2013).
Genetic studies have revealed other proteins involved in the
regulation of pluripotency, such as Sox2, Tbx3, Klf4, and Essrb
(Niwa et al, 2009; Festuccia et al, 2012; Martello et al, 2012).
Within our model, one can consider these factors as
contributors to the stability and dynamics of the central
network that we have defined here. In particular, recent work
has established a critical role of Essrb, which is repressed
by Tcf3 and has the ability to substitute for Nanog
function (Festuccia et al, 2012; Martello et al, 2012). Esrrb
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interacts with and is necessary for Oct4 activity (van den Berg
et al, 2010) and therefore we envision it as an element
that confers robustness to the network and thereby to pluri-
potency, principally through its interactions with Oct4 (see
Supplementary Figure S1).
A plethora of recent studies is making increasingly clear that
pluripotency does not rely on a single linear program of
transcriptional activity, but rather on the convergence of
several molecular activities that balance homeostatically self-
renewal and differentiation. Here, we have shown that post-
transcriptional interactions are an important component of the
mechanism that maintains, and perhaps establishes pluripo-
tency. In particular, our results suggest that a noise-driven
competitive protein interaction network involving Oct4,
Nanog, Tcf3, and b-catenin provide a key element of the
regulatory system that maintains pluripotency. In this net-
work, the levels of b-catenin control the stability and dynamics
of the different complexes. The impact that protein complexes
appear to have on the maintenance of pluripotency places the
focus on the need to characterize their biochemical and
functional properties. While this work (see also Faunes et al,
2013) is a step in that direction, there are technical challenges
that will need to be addressed, for example, determining the
relative amounts of the different complexes in vivo and
establishing the impact that these have on the half lives and
dynamics of the different components. As our model indicates
that these are important variables in the state of the system,
they will have to be addressed experimentally in addition to
the more conventional measurements of the transcriptional
activity of gene regulatory networks.
Materials and methods
Cell culture
Cell lines used are E14Tg2A, EB5, Nanog / (Chambers et al, 2007) ,
ZHBTc4 (Niwa et al, 2002), AG-23191 (Nishiyama et al, 2009),
b-cateninþ / and b-catenin / (Wray et al, 2011), Tcf3þ /þ and
Tcf3 / (Pereira et al, 2006; Yi et al, 2008). All mESC lines were
cultured on gelatine in Serum and leukemia inhibitory factor (LIF)
for or on fibronectin in 2i (N2B27, StemCells, Inc., supplemented
with 1mM PD0325901 and 3 mM Chiron) and LIF. MG-132 was used
as a proteasome inhibitor at 4 mM concentration. Doxycycline was
used to induce the repression of Oct4 expression in the ZHBTc4 cells,
or Oct4 overexpression in the AG-23191 cells (for details, see
Nishiyama et al, 2009 and Faunes et al, 2013). Protein half-lives were
determined by treating E14Tg2Acells with cycloheximide for 2, 4, 6, or
8 h before total protein extraction for western blot analysis or fixation
and immunostaining for quantitative immunofluorescent analysis.
Immunofluorescence and image analysis
Immunofluorescence, antibodies used, and image analysis were
carried out as described previously (Mun˜oz Descalzo et al, 2012).
Fr
eq
ue
nc
y
Total Nanog (molec)
101 104
0
0.05
0.1
0.15
0.2 0 h
24 h
48 h
Fr
eq
ue
nc
y
Total Oct4 (molec)
10 3 10 4
0
0.05
0.1
WT S+L
OE
WT +Chi
OE +Chi
Oct4 (a.u.)
,
+DOX(WT)
–DOX(OE)
+Chi+DOX(WT)
+Chi–DOX(OE)
Fr
eq
ue
nc
y
Nanog (a.u.)
100 101 102
10 –2 10 0 10 –2
0
0.1
0.2
0.3
Fr
eq
ue
nc
y
0
0.1
0.2
0.3
0.4
ZHBTc4 0 h
ZHBTc4 24 h
ZHBTc4 48  h
B
E
C
F
A
D
N
O:N
β:O
T
O:N
β:O
β:O
Nanog
ZHBTc4
AG-23191
Oct4 -catenin Tcf3
β:T
0 h
24 h
48 h
β:T
β:OO
O:NN
O:N
T β:T
T β:T
N
β:T
β:T
N
O:N
β:O
T
O:N
β:O
β:O:N
Nanog Oct4 -catenin Tcf3
β:T
–DOX(OE)
+Chi–DOX(OE)
β:T
β:OO
O:N
N
O:N
T
β:T
β:T
β:O
β
β:O:Nβ:O:N
β:O:Nβ:O:Nβ:O:N O
Figure 6 Analysis of the pluripotent state upon perturbation of Oct4 levels. (A) Pie charts showing how the relative pools of Nanog, Oct4, b-catenin, and Tcf3 evolve
over time upon removing Oct4 from the system for 0, 24, or 48 h as predicted by the model. (B) Distributions of Nanog in ZHBTc cells, untreated (light blue line, 0 h) and
treated with Doxycycline, which represses Oct4 expression, for 24 h (dark-blue line) and 48 h (dashed line). Fluorescence levels (grayscale) were quantified for each
individual cell, binned in logarithmically spaced classes (x axis); the frequency of each bin is shown on the y axis here and in similar graphs. (C) Nanog distributions
exhibited by the TBON model, considering a wild-type situation in Sþ L (light-blue line, 0 h) and after stopping Oct4 production for 24 h (dark-blue line) and 48 h (dashed
line). (D) Pie charts showing how the relative pools of Nanog, Oct4, b-catenin, and Tcf3 change upon Oct4 overexpression and b-catenin stabilization. (E) Oct4
distributions in AG-23191 cells grown in Sþ Lþ Doxycycline (light-green line, þDOX, WT) or removing Doxycycline for 24 h (dark-green line, DOX, OE) which
induces the overexpression of Oct4. The effect of b-catenin stabilization using Chiron was also analysed (dashed lines: light green for the wild-type, and dark green for
the overexpressing conditions). The quantifications procedure was described in (B). (F) Oct4 distributions exhibited by the TBON model considering the same conditions
as in (D).
A protein network promotes pluripotency
S Mun˜oz Descalzo et al
8 Molecular Systems Biology 2013 & 2013 EMBO and Macmillan Publishers Limited
RNA-FISH
Fluorescent in situ hybridization for NanogmRNA, imaging and image
analysis were performed as previously described (Jakt et al, 2013).
Biochemistry
Nanog mutant cells (cre44) and the parental line (CK044) were
cultured in SL or 2i for two passages before lysis in RIPA buffer and
concanavilin A fractionation (see Faunes et al, 2013 for details), and
analysis by western blot using indicated antibodies (see Faunes et al,
2013 for details). Quantitative analysis was undertaken using the Licor
scanner and software.
To determine the half-lives of proteins, E14Tg2Acells were plated on
gelatine in serumþLIF and the next day the medium was changed to
serumþLIFþ 40 mM cycloheximide to inhibit translation. Cells were
lysed using RIPA buffer after 0, 2, 4, and 8h in cycloheximide.
Quantitative western blots were performed by loading equivalent
number of cells in each lane for normalization. Specific antibodies to
Nanog, Oct4, TCF3, and total b-catenin were used and the half-life was
obtained assuming a first-order degradation.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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